The COVID-19 virus has had a dramatic impact on the global capital markets in general and the cannabis/hemp capital markets in particular.
On April 7th, we will be presenting the next event in the Viridian Capital/Marcum LLP webinar series which will focus on the impact of COVID-19 on the Cannabis/Hemp capital markets. Drawing from data in the Viridian Cannabis Deal Tracker, the webinar will present market intelligence on the coronavirus’s impact.
- Capital raising activity for public and private companies
- M&A activity for public and private companies
- Deal sizes and valuations
- Financing structures (debt vs. equity)
- Previously announced transactions
Scott Greiper, President, Viridian Capital Advisors, LLC
Richard Izzi, Partner, Marcum LLP